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ABSTRACT:
Cultured cancer cell lines are a widely used approach in our biology research. 
Our lab uses several human liver cancer lines to study the role of two amino acid 
transporters (ASCT2 and LAT1) during growth. To validate the identity of each line 
for comparative results, a means of positive ID is needed. Short tandem repeat (STR) 
analysis is a method that uses the polymerase chain reaction (PCR) to examine 
'w '  specific DNA regions, called loci, which surround specific genes. Originally used in
forensic analysis and paternity testing, STR analysis has recently become 
incorporated into research laboratories. The reason is due to the estimate that up to 
one third of published research is thought to be erroneous due to misidentification 
of cell lines used in biomedical studies. To proactively address this problem, I have 
embarked on an effort to establish DNA fingerprints for the human cell lines used in 
my lab's cancer research. The study involves the isolation of genomic DNA from 
human liver cancer cell lines and subsequent identification of the cell line via STR 
analysis. The hypothesis is that each cell line investigated will yield a unique DNA 
fingerprint. Genomic DNA was isolated, processed, and submitted to an STR 
analysis core facility for data acquisition. The data presented will reflect my 
conclusions drawn about the unique identities of each cell line used in our cancer 
research lab.
Elevated levels of the transcription factor Myc in human hepatocellular 
carcinoma lines have been implicated in promoting ASCT2 and LAT1 expression as 
well as a glutamine-intensive metabolism. Through western blotting, I have 
examined the level of N-myc and c-myc expression in HCC line and correlated the
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results with ASCT2 analysis. Collectively, the results show that N-myc and ASCT2 
are universally present in both epithelial and mesenchymal human HCC lines, where 
they help drive growth in cells variably reliant on mTOR signaling and glycolysis. 
Subsequently, ASCT2 and LAT1 continue to be common potential therapeutic 
targetsin HCC.
Introduction:
Throughout the past year, I have focused my research on two different 
techniques, STR analysis and western blots, that will come together in a large 
collection of individual projects being performed within my lab group. The overall 
focus of my research lab is to elucidate the role and regulation of amino acid 
transporters ASCT2 and LAT1 in hepatocellular carcinoma and to target these 
transporters as possible therapies for cancer. ASCT2 and LAT1 are coordinate^ 
enhanced in a broad array of human cancers where they associate in the plasma 
membrane and are proposed to work cooperatively to activate mTOR signaling 
through a tertiary-active mechanism involving glutamine (ASCT2) and essential 
branch-chain amino acids (LATl).mTOR, also known as mammalian target-of- 
rapamycin, is a serine/threonine protein kinase that regulates growth, proliferation, 
motility, survival, protein synthesis, and transcription of the cell. My research 
involved performing genomic DNA isolation for STR analysis on fourteen of our 
hepatocellular carcinoma (HCC) lines to establish their unique identities. 
Additionally, I executed a series of western blots (antibody-based detection assays) 
to examine the amount of myc expression present in each of the fourteen HCC lines 
(7 Group I (epithelial) and 7Group II (mesenchymal)) and in a control human live 
cell line known as THLE5B.Metastatic cancer usually requires an EMT (epithelial to 
mesenchymal transition) because mesenchymal cells tend to be more aggressive 
since they do not have adhesion and they are more motile. Also, the two cell types 
look different from each other. Epithelial cells are round and more normal looking. 
Mesenchymal cells are more elongated and spindle-shaped. THLE5B is an 
immortalized human liver epithelial cell line, not tumorigenic, and the control for 
my experiment. Myc proteins are dimeric transcription factors that regulate the 
expression of genes including glutamine transports such as ASCT2. There are three
isoforms of myc: c-myc, N-myc, and L-myc. Myc proteins promoteproliferation and 
apoptotic pathways vital for progression in cancer. I have examined c-myc and N- 
myc expression in the fifteen HCC cell lines that are culturing in lab. The main goal 
of my lab's research is to examine myc expression across all the HCC lines as a 
function of how much ASCT2 and LAT1 is expressed per line. In other words, at the 
genomic level, does myc expression correlate with ASCT2 expression? I have looked 
at c-myc and N-myc expression and another person in my lab is looking at ASCT2 
and LAT1 expression, then we will combine our data sets to examine the results. 
Furthermore, the STR analysis is central to our research because it establishes and 
validates the unique identity of each HCC line. This is important because we draw 
comparative conclusions between HCC lines and need to be confident that their 
unique identities are not questioned upon publication of our results.
STR Analysis in Cell Line Identification 
Overview:
W ' Short tandem repeat (STR) analysis is a method used in forensic science that
examines specific regions that differ between individuals called loci. STR analysis is 
used for human identity testing: forensic cases, paternity testing, mass disasters, historical 
investigations, and missing person investigations. The genome o f each individual is 
unique, with the exception o f identical twins, and is inherited from parents. A short 
tandem repeat is also known as a microsatellite, which consists o f one to six nucleotides 
repeated hundreds o f times in a row on the DNA strand and are used as molecular 
markers. Through STR analysis, the exact number o f repeating regions can be measured. 
The STR regions are extremely polymorphic in nature and this property allows for 
discrimination between DNA profiles and furthermore between individuals. The 
likelihood that any two individuals (except identical twins) will have the same 15
W ' autosomal STR loci DNA profile can be as high as one in 837 trillion (1012)[1]. STR
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Analysis is used to detect various amounts o f specific loci, identify a match between a 
cell line and an existing STR profile, and it can detect the presence o f multiple cell lines.
There are many reasons to perform STR analysis. My purpose for performing 
STR analysis is to authenticate our human hepatocelluar carcinoma cell lines by 
confirming the identity o f an acquired line in comparison to a known profile. This 
procedure can also be used to confirm a relationship with a parental DNA profile; 
identifying the father. A large reason as to why STR analysis is becoming more common 
in laboratories is to rule out culture contaminations. John R. Masters and co-authors 
state, “Estimates from national testing services indicate that up to 36% o f cell lines are o f 
a different origin or species to that claimed” [2] .These large amounts o f contamination 
are hindering the validity o f research published. In order to control this problem, cell 
lines should be authenticated through STR analysis before freezing, once every two
vw /
months that the culture is actively growing, i f  the results are inconsistent, and before 
publication [3]. However, the more often cells are authenticated the better because this 
provides assurance in the validity o f the research.
In November o f 2007, the National Institutes o f Health (NIH) sent out a notice in 
regarding the importance o f authenticating cultured cell lines. The notice explains how 
there have been several instances in the past in which research has been based on 
misidentified or contaminated cultures. This is a serious problem and it can greatly affect 
the outcomes o f the research. Contaminated or misidentified cell lines influence the 
ability to replicate previous results in scientific research and consequently it is difficult to 
progress in science [4]. I f  cell lines are not being authenticated, then scientists cannot be
sure o f the quality o f their research and publications. Additionally, much time and
W
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money could be wasted i f  cell line identities are not confirmed and they end up being 
wrong. Many o f these issues would be avoided by authenticating the cell lines with STR 
analysis.Follow the STR typing, a human cell line authentication report is created and 
you can compare it to the STR profile obtained by the core facility at Johns Hopkins 
(who is performing the analysis). There are three possible outcomes: match, exclusion 
(non-match), or inconclusive [5].
The Federal Bureau o f Investigation (FBI) has played a strong role in the 
development o f DNA technology for the use o f identifying individuals. On October 12, 
1998, the FBI launched its nation-wide DNA database named Combined DNA Index 
System (CODIS). All o f the CODIS STRs are tetrameric repeat sequences, which means 
a set o f four nucleotides {e.g. (AATG)(AATG)(AATG)} is repeated several times. 
CODIS is extremely universal considering it links all 50 states and has over 1.8 million 
STR profiles [6]. It has the capability to search criminal DNA profiles similar to those 
for fingerprints. TheShort Tandem Repeat DNA Internet Database (STRBase)website has 
been created to establish a core set o f literature that can be used by all scientists. The 
website includes facts and sequence information on STR analysis, population data, and a 
reference list o f commonly used systems and PCR primers. These databases are effective 
because a majority o f crimes are committed by repeat offenders and the databases can be 
linked from a national level to state and local levels.
The same technology is used here to identify HCC lines for my experiment in Dr.
Bode’s lab, I isolated the DNA from fourteen human hepatocellular carcinoma lines that
we culture in lab. Group I cell lines (epithelial) were HepG2, Hep3B, Huhl, Huh2, Huh7,
PLC/PRF/5, and Tong. Group II cell lines (mesenchymal) were SKHep, Focus,
W
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SNU2234, SNU2236, SNU2237, SNU2238, and Mahlavu. Since our lab at Northern 
Illinois University (NIU) does not have the proper equipment to perform STR analysis, 
we are sending the DNAI isolated to the Johns Hopkins Core Facility. The Fragment 
Analysis Facility (FAF) at Johns Hopkins is going to perform STR analysis on each of 
our HCC lines to identify the different cell line profiles, and then we will be able to 
confirm the identity with our known profiles. The known profiles can be received by the 
repository at which the HCC lines came from, such as American Type Culture Collection 
(ATCC) for example. The results o f the STR profiling will include allele designations, 
the raw data for the alleles such as size in base pairs, peak height, peak area, and screen 
shots o f the electropherograms [3].
Materials and Methods:
W
The general procedure that is used to carry out STR analysis starts out by 
collecting approximately 1 X  105 cells and extracting the DNA from those cells. Then 
the DNA extracted is quantitated because you need to know how much DNA is present 
for the polymerase chain reaction amplification (PCR). Multiple STR markers are then 
copied through PCR through use o f selective DNA primers. PCR produces millions o f 
copies for each DNA segment of interest and thus permits very minute amounts o f DNA 
to be examined. Following PCR, the DNA segments are separated by length in a 
capillary gel electrophoresis procedure. Finally, the sample genotype is determined and 
that is compared with known profiles for the specific cell lines.
In our lab at NIU, I have been able to perform the beginning o f the STR analysis




(Madison, WI), I have extracted DNA from the fourteen cell lines identified earlier. For 
each HCC line I performed the following procedure:
1. As each line was passed, I obtained tissue culture cells and trypsinized them and 
then centrifuged them at 500x g for 5 minutes in order to pellet the cells.
2. I removed the supernatant, leaving behind the cell pellet plus 10-50 pi of residual 
liquid.
3. I washed the cells with 200 pi of PBS and centrifuged again.
4. I removed the PBS wash and vortexedthe 15ml tube to resuspend the cells.
5. I added 600 pi of Nuclei Lysis Solution and pipeted to lyse the cells.
6. I added 35 pi of a 10 mg/ml solution of Proteinase K.
7. I incubated the sample overnight at 55oC with gentle shaking.
8. The following day, I added 200 pi of Protein Precipitation Solution to the room 
temperature sample and vortexed vigorously for 20 seconds.
9. I chilled the sample on ice for 5 minutes then transferred my sample from a 
15 ml test tube to a 1.5 ml microcentrifuge tube.
1 0 .1 centrifuged my sample for 4 minutes at 15,000x g. (The precipitated protein 
formed a tight white pellet at the bottom.)
1 1 .1 transferred the supernatant containing the DNA to a new 1.5 ml 
microcentrifuge tube containing 600 pi of room temperature isopropanol.
1 2 .1 gently mixed the solution by inversion until the white thread-like strands of 
DNA formed a visible mass. **
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* *  Note, i f  the white thread-like strands did not form.. .1 added one-tenth of the sample 
volume of sodium acetate to the sample and placed in -80°C for 30 minutes. Then I 
centrifuged the sample and the DNA pellet formed.
13.1 centrifuged for one minute at 15,000x g at room temperature and a small DNA 
white pellet appeared at the bottom of the tube.
1 4 .1 decanted the supernatant and added 600 pi of room temperature 80%  ethanol 
and inverted the tube several times to wash the DNA. I centrifuged again for 
one minute at 15,000 x g at room temperature.
1 5 .1 aspirated the ethanol using a gel pipette tip and let the pellet air-dry while the 
tube is inverted.
1 6 .1 added 100 pi of DNA Rehydration Solution, and rehydrated the DNA by 
incubating the solution overnight at 4°C.
17. The following day, I transferred the DNA solution to storage at -20°C.
1 8 .1 used the NanoDrop Spectrophotometer to read the DNA concentration of each 
sample. Johns Hopkins requires that I send a minimum of 500 ng o f DNA at a 
concentration o f 100 ng/pl. Each cell line had a sample volume of 100 pi and 
every concentration was above 100 ng/pl [see the STR Profiling Request 
table that we submitted to Johns Hopkins on page 14).
1 9 .1 prepared all my samples and they were sent to Johns Hopkins for the rest o f the 
STR analysis.
Results:
In general, a human cell line authentication report will contain 15 autosomal STR 
loci plus Amelogenin (sex determining marker) and the raw data showing peaks o f the 
different loci. One peak at a locus means the cell line is homozygous at that locus and
ww
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two peaks at a locus means heterozygosity. Below each peak, the top number is the 
amount o f short tandem repeats, and the bottom number is the height o f the peak. For 
cancer cells, there may be more than two peaks present or the peak heights may be 
unbalanced [7].
Unfortunately, I will not be able to receive the results from Johns Hopkins Core 
Facility in time to present my results as they were just shipped out upon submission of 
this thesis. However, I can explain the reason we in Dr. Bode’s lab believe to have 
individualized lines, and once we receive the STR analysis results they will confirm our 
belief.
I believe every HCC line is unique and individualized based on the morphology, 
growth rates, and results from my western blots. To best explain the morphology o f the 
HCC lines I have attached pictures o f a few group I cell lines (Hep3B, HepG2, and 
Huh2), a few group II cell lines (Focus, Mahlavu, and SKHep), and a control cell line 
(THLE5B). Some noticeable morphology characteristics that may be seen in the 
photographs are:
• Group I cells are round and normal looking
• Group II cells are elongated and spindle-like
• Hep3B, HepG2, and Huhl all grow in islands
• Huh2 grows as a contiguous monolayer (sheet)
• SNU2234, SNU2236, SNU2237, and SNU2238 are all rounded with spiky 
projections
• Mahlavu and THLE5B are both very similar with spiky looking projections
o THLE5B looks similar to the image o f a magnet when it has iron fibers 
protruding off the ends
The growth rates for the cell lines differ markedly from as quickly as a few days to up to 
a week or longer. The fastest growing cell lines are SKHep, Focus, and Huh2. These 
lines will grow from plating to confluency in approximately three days. The slowest 
growing HCC line is SNU2236 and it takes about seven days to grow to confluency. 
Tong and PLC/PRF/5 are also slow growing lines that take about four and half days to 
reach confluency. The results o f my western blots for N-myc and c-myc show that each
10
































For each sample the volume of DNA was 100 pi. The DNA preparation method was 
Promega Wizard Genomic DNA Purification Kit and these samples were obtained from 
the HCC cultured cell lines.
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Western Blotting for N-mvc and c-myc 
Overview:
A western blot is an analytical technique used to detect specific proteins (N- 
myc and c-myc) in given samples (group I and group II HCC lines). This technique 
consists of gel electrophoresis to separate the proteins within the samples by length 
and then the proteins are transferred onto a PVDF membrane where they can be 
probed using antibodies specific for N-myc and c-myc.
Myc proteins (c-myc, N-myc, and L-myc) are proto-oncogenes and one of the 
most studied genes in cancer. They are basic helix-loop-helix leucine zipper 
transcription factors that localize in the nucleus and form heterodimers with other 
basic helix-loop-helix molecules, such as Max, Myc, or Mad [7]. C-Myc/Max 
heterodimers bind to a consensus Enhancer Box sequence (E-box site) in the target 
promoter to transcribe other downstream gene targets important for proliferation, 
apoptosis, and differentiation[8]. Recent discovers have been made of E-boxes 
upstream from a lot of glutamine transporters including ASCT2 and some of the 
glutamine metabolizing enzymes like glutaminase.
The current hypothesis in the scientific field is that myc is required for 
activating the transcription of genes that are involved in creating a glutamine­
intensive metabolic profile in the cell, which is typical in many cancers. This 
environment in the cancerous cells support the Warburg effect in which cancer cells 
produce energy via accelerated consumption of glucose throughhigh rates of aerobic 
glycolysis; even in the presence of sufficient oxygen amounts [9].
In normal cells, c-myc gene is tightly regulated and only express when the 
cells actively divide. In cancer cells, c-myc gene is expressed in an uncontrolled 
manner as the result of genetic abnormalities [10]. C-myc was identified as capable 
of transformation by retroviral promoter insertion. While N-myc was identified as a 
myc homolog amplified in neuroblastoma tumors (thus the designation "NM-myc). 
Amplification of N-myc is a very distinctive indicator of high-risk, aggressive 
disease[7].
The first goal of the western blots was to see if either N-myc or c-myc were 
expressed in all of the HCC lines. From those results we compared the expression of 
ASCT2 in all of the HCC lines. These comparisons were made to check ifmyc 
expression is present then we hypothesized that ASCT2 expression would be 
present as well. Looking more specifically we could examine which of the two myc 
isoforms (c-myc or N-myc) associate more closely with ASCT2.
M aterials and Methods:
The first part of a western blot included preparing the proteinsamples from 
HCC cell lines. This process involved extracting the protein from the cell lines and 
reading the concentration on the Nanodrop machine. In some cell lines it was 
necessary to double up the protein concentration to have enough to get valid 
results. The western blotting procedure is a three day process. The first day 
consisted of creating all the necessary solutions: IX  running buffer and IX  transfer 
buffer. Then theprotein-extracted samples are prepared for loading into the gel 
W / cassette, which can be run one or two gels at one time depending on the amount of
samples analyzed. Calculations were performed on the computer in an Excel 
spreadsheet that determines the amounts of sample volume, lysis buffer, sample 
loading buffer, and 1M DTT to add to the samples for loading the gel. For each gel 
that was run, 1 used a 3-Color Protein Molecular Weight Marker on the far left and a 
Biotinylated protein ladder on the far right.I loaded 10 pi of the 3-Color in the first 
well, 20 pi of each sample in the next wells, and 5 pi of Biotin in the last well. The gel 
was run with the IX  running buffer for 40 minutes at 200 volts when the Bio-Rad rig 
was used. These values can change depending on the type of gel rig used. The usual 
order for HCC samples in the gel is as follows for each well in the gel:
Group I Gel:
3 Color -  Space -  HepG2 -  Hep3B -  Huhl -  Huh2 -  Huh7 -  PLC/PRF/5 -  Tong -  
THLE5B -  Space -  Biotin 
Group II Gel:
, 3 Color -  Space -  SKHep -  Focus -  SNU2234 -  SNU2236 -  SNU2237 -  SNU2238 -
Mahlavu -  THLE5B -  Space -  Biotin
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While the gels ran I prepared for the electro-transfer of proteins. The 
preparation included cutting out two 10 cm by 10 cm sheets of filter paper and one 
8.5 cm by 8 cm PVDF membrane per gel.Next, I prepared the PVDF membrane for 
the sandwich assembly by first placing it in 25 ml of Methanol for 15 seconds. Then 
I placed it in 25 ml of Nanopure H2O for 2 minutes. Finally, I transferred the 
membrane to 25 ml of IX  transfer buffer for at least 5 minutes. Additionally, I had 
the two pieces of filter paper and two foam pads soak in IX  transfer buffer per gel 
ran.
Once the gels finished running I removed the gel from the cassette and 
transferred it to a container with IX  transfer buffer to equilibrate for 10 minutes. 
Next, I assembled my sandwich for electrophoretic transfer. I placed one foam pad 
and one piece of filter paper on the black side of the hinged black (Cathode, -) and 
red (Anode, +) plastic sandwich cassette. On top of the filter paper the gel is placed 
(face-down) and drizzled with transfer buffer and the air bubbles rolled out. On top 
of the upside down gel the PVDF transfer membrane was placed and a filter paper 
and foam pad completed the "sandwich".The sandwich cassette was clipped 
together and placed in the tank transfer unit. One sandwich cassette was made per 
membrane and multiple cassettes can be run in the transfer unit at one time. The 
cassette was placed in the transfer unit along with the 1.3 L of IX  tank transfer 
buffer and the unit ran for 90 minutes at 70 volts. There was a circulating chiller 
connected to the transfer unit while it ran to prevent heat buildup, which can 
compromise the transferred protein resolution. When the transfer was complete 
the membrane was hung up to dry overnight. In order to keep track of the 
orientation of the membrane, the lower right hand corner was cut away when it 
wasfacing-up.
Day two of western blotting consisted of washing the membrane with IX  
TBST (Tris-Buffered Saline + 0.1%  Twee-20 detergent) for 5 minutes and incubating 
the membrane in 25 ml of blocking buffer for one hour on the rocker. Blocking 
buffer consists of 5% BSA in TBST. Then I washed the membrane again with IX  
TBST for 5 minutes. Next, I placed the membrane in primary antibody dilution 
buffer. This buffer consists of 10 ml of blocking buffer and the proper amount of
primary antibody. For N-myc it is a 1 to 400 dilution ratio so I added 25 pi to the 10 
ml blocking buffer. For c-myc it is a 1 to 1000 dilution ratio so 1 added 10 pi to the 
10 ml blocking buffer. The primary antibody in blocking buffer was incubated with 
the membrane on the shaker at 4°C overnight.
Day three of western blotting consisted of secondary antibody incubation 
and reading the membrane results with Chemiluminescence. First, I washed the 
membrane three times for 5 minutes each with 15 ml of TBST on the shaker. Then I 
incubated the membrane with the species appropriate HRP (horse radish 
peroxidase)-conjugated secondary antibody (1 :2000 TBST) for one hour on the 
shaker. This mix consisted of 10 ml of blocking buffer 5 pi of the secondary 
antibody, which is goat anti-rabbit HRP IgG, and 5 pi of the anti-biotin ladder. 
Following incubation I washed the membrane again three times for 5 minutes each 
with new TBST. I then performed the chemiluminescencedetection step on the 
membrane. This process involved incubating the membrane with 10 ml of LumiGLO 
(a chemical which is converted to a photon (light) by HRP) for one minute followed 
by image acquisition in the chemiluminescence detector. The membrane 
was wrapped in saran wrap and stored at -20°C.
Results:
Based on the western blot images I have learned about N-myc and c-myc 
expression in the fourteen HCC line and ThLE5B. It is apparent that N-myc is 
expressed in all of the cell lines. In contrast, it looks as though c-myc is variably 
present in the cell lines. C-myc expression was not present in Hep3B, PLC/PRF/5, 
and Tong of the group I cell lines and 2 2 3 4 ,2 2 3 7 , and 2238 of the group II cell lines. 
However, I am currently awaiting a new c-myc antibody whichl am expecting will 
produce more clear results. Currently, I can state that all HCC lines are N-myc 
positive, ASCT2 positive, and variably c-myc positive, with no obvious correlation 
between specific myc isoform and transporter expression levels. ASCT2 and LAT1 
results were obtained by a fellow lab mate. Following up on this information, 
another person in my lab is looking at ASCT2 and myc expression within rodent 
lines, with the hypothesis that ASCT2 is expressed if myc expression is present.
The N-myc blots showed some interesting results including double band 
formation in some of the cell lines (an upper molecular weight band and a lower 
molecular weight band). These cell lines are Huhl, Tong, SNU 2238, and THLE5B. 
We are currently investigating if a protease cleaved the upper molecular weight 
band somewhere that it made into a shortened isoform, or it could be that it is just 
an mRNA that gets alternatively spliced for myc and they both share that same 
epitope that the antibody recognizes.
Conclusion:
The results from this study indicate that the fourteen human HCC lines are 
unique (STR results will confirm this observation), and that N-myc but not c-myc is 
universally expressed in human HCC cells. These results will be combined with 
others to provide a comprehensive study on the expression of two transporters 
implicated in cancer and their relationship to the oncogenicmyc family of 
transcription factors. These results will give great insights into the metabolic wiring 
W ' of liver cancer and its drivers with the ultimate goal of developing selective
therapies for this difficult cancer.
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Group I Cell Lines:
M HepG2, Hep3B, Huhl, Huh2, Huh7, P/5, Tong, ThLE5B, space, Biotin
Group II Cell Lines:
N-myc SkHep, Focus, 2234, 2236, 2237, 2238, Mahlavu, ThLE5B, Space, Biotin
C-myc SkHep, Focus, 2234, 2236, 2237, 2238, Mahlavu, ThLE5B, Space, Biotin
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These are the first two western blots 1 performed on c-myc:
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